Blood cancer is the term used to cover a number of malignant diseases of the bone marrow or blood-forming system. Because of the cancerous cells, the blood can no longer perform its vital tasks, such as fighting infections, transporting oxygen or stopping bleeding.
Blood cancer patients can often only overcome the disease with the help of a blood stem cell donation from a suitable donor. In fact, in the case of leukaemia and malignant lymphomas, the transfer of healthy blood stem cells is the only chance of a cure.
Leukaemia is the word used to describe a series of diseases in which there is an increase of non-functional white blood cells. Malignant lymphomas are divided into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukaemia) according to their different characteristics.
The altering of lymphatic tissue leading to the swelling of the lymph nodes and enlargement of the spleen. Malignant lymphomas are divided according to their different characteristics into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukemia), which originate from the lymph nodes.
The protection and security of your data is of paramount importance to us here at DKMS. We will only record, process and use your personal data in accordance with your consent. We adhere to legal guidelines on the use of any data and only keep what is legally permissible and necessary in order to find a suitable blood stem cell donor.
We are registered and adhere to the Data Protection Act 2018 and ensure that all employees are fully up-to -date and trained in this Act. Your personal data will be stored on our secure DKMS database and only your anonymised data will be transmitted to registries to find out if you are a potential match for a patient (data such as HLA tissue characteristics, age, gender and donor number).